Heidelberg Pharma AG filed its Annual on Mar 24, 2023 for the period ending Nov 30, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 EUR | -1.01% | -1.35% | -21.66% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.66% | 150M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.87% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG
- Heidelberg Pharma AG Auditor Raises 'Going Concern' Doubt